Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
T. Kim, B.-S. Park, S. Heo, H. Jeon, J. Kim, D. Kim, S. Kook Lee, S.-Y. Jung, S.-Y. Kong, T. Lu
The paper identifies FYN and KDM4 as synergistic targets for enhancing TKI efficacy in triple negative breast cancer through CRISPR screens and mechanistic analysis.
bioRxiv · Nov 8, 2023Cancer Biology